Marinomed Biotech AG's total assets for Q2 2024 were €11.32M, a decrease of -22.51% from the previous quarter. DE:93Z total liabilities were €31.87M for the fiscal quarter, a 28.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.